Pittenger & Anderson Inc’s GeneDx Holdings WGS Stock Holding History

Pittenger & Anderson Inc’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4	Closed	-$24	–	475
2023 Q2	$24	Buy	+4	New	+$32	﹤0.01%	465

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Pittenger & Anderson Inc's WGS Position: Q3 2023 in Review

Pittenger & Anderson Inc sold out of GeneDx Holdings (WGS) in Q3 2023, closing a stake of 4 shares — an estimated $24 sold.

Pittenger & Anderson Inc first reported a position in WGS in Q2 2023 and held it in 1 quarter. The position peaked at $24 in Q2 2023. 53 funds tracked by Wall St. Rank hold WGS as of Q3 2023.

Pittenger & Anderson Inc reported no remaining GeneDx Holdings position as of Q3 2023 after selling out during the quarter.
Pittenger & Anderson Inc sold 4 GeneDx Holdings shares in Q3 2023, an estimated $24.
Pittenger & Anderson Inc first reported a position in GeneDx Holdings in Q2 2023 and held it in 1 quarter.
Pittenger & Anderson Inc's GeneDx Holdings position peaked at $24 in Q2 2023.
53 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2023.

Based on Pittenger & Anderson Inc's 13F filing for Q3 2023, filed 2 Nov 2023.